Lobbying

Horizon Government Affairs on Behalf of U.S. Pharmacopeial Convention's latest lobbying report covers Q3 2025, at $7,000. Its first report covers Q2 2025; the issues it reports most are Health Issues and Pharmacy.

Horizon Government Affairs on Behalf of U.S. Pharmacopeial Convention

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q2 2025
The first quarter a report named it

Lobbying by quarter

Horizon Government Affairs on Behalf of U.S. Pharmacopeial Convention lobbying by quarter
Horizon Government Affairs on Behalf of U.S. Pharmacopeial Convention lobbying by quarter
QuarterAmountReports
Q2 2025$7,0002
Q3 2025$7,0002
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$7,000 · 4 reports
  • Pharmacy$7,000 · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Executive Office of the President (EOP)2 reports
  • HOUSE OF REPRESENTATIVES2 reports
  • Office of Administration2 reports
  • President of the U.S.2 reports
  • SENATE2 reports

Firms it paid

Firm
Old North Strategies$14K2 quarters
First Principles Strategies$02 quarters

Former officials lobbying for it

Former position
JOSEPH ROBERT MURRAYRepublican Study Committee; Rep. Mark Meadows; Senator Ron JohnsonQ3 2025
JOSEPH WAYNE KING iiformer Deputy Chief of Staff Congressman Mark Meadows & former Sr. Advisor Congressman Greg Murphy, M.D.Q3 2025

Lobbying reports

Filed by
25/11/19for Q3 2025First Principles StrategiesUnder $5,000
25/10/25for Q3 2025Old North Strategies$7,000
25/08/12for Q2 2025First Principles StrategiesUnder $5,000
25/07/24for Q2 2025Old North Strategies$7,000
25/04/25for Q2 2025Old North StrategiesUnder $5,000
25/04/25for Q2 2025First Principles StrategiesUnder $5,000